3D Medicines (HKSE:01244) FCF Yield % : -8.84 (As of May. 16, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 3D Medicines's Trailing 12-Month Free Cash Flow is HK$-164.9 Mil, and Market Cap is HK$1,864.0 Mil. Therefore, 3D Medicines's FCF Yield % for today is -8.84%.

The historical rank and industry rank for 3D Medicines's FCF Yield % or its related term are showing as below:

HKSE:01244' s FCF Yield % Range Over the Past 10 Years
Min: -111.91 Med: -12.03 Max: -4.89
Current: -8.84

During the past 4 years, the highest FCF Yield % of 3D Medicines was -4.89%. The lowest was -111.91%. And the median was -12.03%.

HKSE:01244's FCF Yield % is ranked better than
60.41% of 1556 companies
in the Biotechnology industry
Industry Median: -14.305 vs HKSE:01244: -8.84

3D Medicines's FCF Margin % for the quarter that ended in Dec. 2023 was 8.13%.

3D Medicines FCF Yield % Historical Data

The historical data trend for 3D Medicines's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines FCF Yield % Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-3.42

-8.36

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-4.71	-1.54	2.54

Competitive Comparison of 3D Medicines's FCF Yield %

For the Biotechnology subindustry, 3D Medicines's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 3D Medicines's FCF Yield % falls into.

3D Medicines FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

3D Medicines's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-164.873	/	1972.70148
	=	-8.36%

3D Medicines's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	25.1	*	2	/	1972.70148
	=	2.54%

3D Medicines FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

3D Medicines FCF Yield % Related Terms

Thank you for viewing the detailed overview of 3D Medicines's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

3D Medicines (HKSE:01244) Headlines

No Headlines